Jun Ishigooka

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Depressive Symptoms

Top Venues

Psychiatry and clinical neurosciences

Neuropsychiatric disease and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Jun Ishigooka, Kazuyuki Nakagome, Tetsuro Ohmori, Nakao Iwata, Ken Inada, Jun-Ichi Iga, Taro Kishi, Kiyoshi Fujita, Yuka Kikuchi, Toshiaki Shichijo, Hideaki Tabuse, Shotatsu Koretsune, Hiroshi Terada, Haruko Terada, Toshifumi Kishimoto, Yuichiro Tsutsumi, Kazutaka Ohi
Randomized open-label study of second-generation antipsychotics for the treatment of schizophrenia: 104-week final results of the JUMPs study assessing treatment discontinuation, remission, and social functioning. BMC psychiatry 24 (1) (2024)
Jun Ishigooka, Kazuyuki Nakagome, Tetsuro Ohmori, Nakao Iwata, Ken Inada, Jun-Ichi Iga, Taro Kishi, Kiyoshi Fujita, Yuka Kikuchi, Toshiaki Shichijo, Hideaki Tabuse, Shotatsu Koretsune, Hiroshi Terada, Haruko Terada, Toshifumi Kishimoto, Yuichiro Tsutsumi, Yoshiki Kanda, Kazutaka Ohi, Kanji Sekiyama
Discontinuation and remission rates and social functioning in patients with schizophrenia receiving second-generation antipsychotics: 52-week evaluation of JUMPs, a randomized, open-label study. Psychiatry and clinical neurosciences (2021)
Jun Ishigooka, Tatsuya Hoshino, Takumi Imai, Hisako Yoshida, Midori Ono, Mihoko Ota, Yoshiya Moriguchi, Keita Fujikawa, Ayumi Shintani, Jovelle L Fernandez
Patient and Physician Perspectives of Depressive Symptoms and Expectations for Treatment Outcome: Results from a Web-Based Survey. Neuropsychiatric disease and treatment 17 (2021)
Masashi Ikeda, Jun Ishigooka, Ichiro Naoi, Masahiro Matsumoto, Yuichi Kanamori, Hiroshi Nakamura, Teruhiko Higuchi
Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study. CNS drugs 34 (1) (2021)